NFTs were moderately to intensively immunoreactive for both 3R and 4R tau in two of the three TBI cases (Cases 12 and 13), similar to NFTs observed in non-injured control AD and PART cases [4]. The gene discussed is MAPT; the disease is Alzheimer disease.